pregabalin brands
12 registered brands containing pregabalin in Botswana.
Pregabalin
PubChem CID 5486971Molecular formula: C8H17NO2
Although the mechanism of action has not been fully elucidated, studies involving structurally related drugs suggest that presynaptic binding of pregabalin to voltage-gated calcium channels is key to the antiseizure and antinociceptive effects observed in animal models. By binding presynaptically to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, pregabalin modulates the release of several excitatory neurotransmitters including glutamate, substance-P, norepinephrine, and calcitonin gene related peptide. In addition, pregabalin prevents the alpha2-delta subunit from being trafficked from the dorsal root ganglia to the spinal dorsal horn, which may also contribute to the mechanism of action. Although pregabalin is a structural derivative of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), it does not bind directly to GABA or benzodiazepine receptors. Pregabalin is an anticonvulsant that is structurally related to the inhibitory CNS neurotransmitter gamma-aminobutyric acid (GABA). Pregabalin also has demonstrated analgesic activity. Although pregabalin was developed as a structural analog of GABA, the drug does not bind directly to GABA-A, GABA-B, or benzodiazepine receptors; does not augment GABA-A responses in cultured neurons; and does not alter brain concentrations of GABA in rats or affect GABA uptake or degradation. However, in cultured neurons, prolonged application of pregabalin increases the density of GABA transporter protein and increases the rate of functional GABA transport. Pregabalin binds with high affinity to the alpha2-delta site (an auxiliary subunit of voltage-gated calcium channels) in CNS tissues. ... In vitro, pregabalin reduces the calcium-dependent release of several neurotransmitters, including glutamate, norepinephrine, and substance P, possibly by modulation of calcium channel function. Pregabalin does not block sodium channels, is not active at opiate receptors, and does not alter cyclooxygenase enzyme activity. It is inactive at serotonin and dopamine receptors and does not inhibit dopamine, serotonin, or noradrenaline reuptake. Pregabalin is a potent ligand for the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system that exhibits potent anticonvulsant, analgesic, and anxiolytic activity in a range of animal models. ... Potent binding to the alpha-2-delta site reduces depolarization-induced calcium influx with a consequential modulation in excitatory neurotransmitter release. Pregabalin has no demonstrated effects on GABAergic mechanisms. ... For more Mechanism of Action (Complete) data for PREGABALIN (6 total), please visit the HSDB record page.
Source: PubChem (NCBI) ยท compound 5486971
| Product | Manufacturer | Status | Country |
|---|---|---|---|
| CP-PREGABALIN 300 Solid oral (Hard Gelatin Capsules) |
Steril-gene Life Sciences Ltd | Registered/Compliant | Botswana |
| LYRICA CAPSULE |
Godecke | Registered/Compliant | Botswana |
| LYRICA CAPSULE |
Godecke | Registered/Compliant | Botswana |
| LYRICA CAPSULE |
Godecke | Registered/Compliant | Botswana |
| LYRICA CAPSULE |
Godecke | Registered/Compliant | Botswana |
| NEUROGAB 150 Capsule |
Macleods Pharmaceuticals | Registered/Compliant | Botswana |
| NEUROGAB 75 CAPSULE |
Macleods Pharrmaceuticals Limited | Registered/Compliant | Botswana |
| PREGABALIN DENK 150 MG Hard capsules |
Temmler Pharma | Registered/Compliant | Botswana |
| PREGABALIN DENK 75 Hard capsules |
Temmler Pharma | Registered/Compliant | Botswana |
| PREGALEP 150 Uncoated Tablets |
Neuraxpharm Pharmaceuticals, S.l | Registered/Compliant | Botswana |
| PREGALEP 25 Uncoated tablets |
Neuraxpharm Pharmaceuticals, S.l | Registered/Compliant | Botswana |
| PREGALEP 75 Uncoated tablets |
Neuraxpharm Pharmaceuticals, S.l | Registered/Compliant | Botswana |